SP1 reduces autophagic flux through activating p62 in gastric cancer cells.
Mol Med Rep
; 17(3): 4633-4638, 2018 03.
Article
em En
| MEDLINE
| ID: mdl-29328444
Gastric cancer is the most common type of gastrointestinal cancer, causing mortality worldwide. However, the underlying molecular mechanism in gastric cancer progression remains unclear. The autophagic flux was determined in gastric cancer cells overexpressing or inhibiting Sp1 transcription factor (SP1) using western blotting, reverse transcriptionpolymerase chain reaction and immunofluorescence staining. Luciferase and ChIP assays were performed to detect the potential underlying mechanism of SP1 in gastric cancer cells. Lastly, immunohistochemistry was also performed on SP1 and p62 expression levels in human gastric cancer specimens. It was demonstrated that SP1 diminished autophagic flux via activating p62 in gastric cancer. Moreover, SP1 deficiency increased the rate of autophagy of gastric cancer cells. Notably, it was observed that SP1 enhanced the expression levels of p62 by directly binding to the promoter of p62. Analysis of gastric cancer specimen staining established that p62 expression levels were increased in SP1positve gastric tissues. The present study provided evidence for a novel mechanism regulating autophagy in gastric cancer cells.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fator de Transcrição Sp1
/
Proteínas de Ligação a RNA
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article